Outpatient Infusion Centers
Freestanding outpatient infusion centers delivering IV medications, biologics, and specialty drug therapies across oncology, rheumatology, neurology, and other chronic disease specialties.
- 5
- Verticals
Overview
Outpatient Infusion Centers deliver IV medications, biologics, and specialty drug therapies outside the hospital across oncology, rheumatology, neurology, and other chronic-disease specialties. The site-of-care shift from hospital outpatient departments to lower-cost freestanding and physician-office infusion is a powerful driver.
Demand is propelled by the growth of biologics and specialty infusibles and by payers steering infusion to lower-cost settings. It is a fast-consolidating, ancillary-rich category (often attached to specialty practices) attracting private equity. The federal data category is broad, covering other outpatient care centers as well.
Market snapshot
- Market size
- ~$70B
- Growth
- ~5.4%CAGR (2017–22, nominal)
- Companies
- ~21,000
U.S. Census Bureau 2022 CBP/Economic Census, NAICS 621498 (All Other Outpatient Care Centers) — a broad category beyond infusion alone.
Business model & economics
- Revenue model
- Drug margin plus infusion-service reimbursement
- Recurring revenue
- High — recurring chronic infusion
- EBITDA margin
- Drug-margin- and site-of-care-driven
- Capex intensity
- Moderate
- Site-of-care shift to lower-cost freestanding infusion.
- Biologics and specialty infusibles drive growth.
- Often an ancillary attached to specialty practices.
M&A deal context
Who’s acquiring
What’s driving deals
- Site-of-care shift to lower-cost infusion.
- Biologics and specialty-drug growth.
- Ancillary-driven specialty-practice consolidation.
Verticals in this segment
- 4.10.18.1Independent Infusion Centers
Freestanding outpatient infusion clinics serving multiple specialty referral streams.
- 4.10.18.2Infusion Management Organizations
PE-backed platforms consolidating outpatient infusion center networks.
- 4.10.18.3Neurology & Multiple Sclerosis Infusion
Infusion centers delivering neurological disease-modifying biologics and IV therapies.
- 4.10.18.4Oncology Infusion Centers
Outpatient infusion sites delivering chemotherapy and oncology biologic infusions.
- 4.10.18.5Rheumatology & Immunology Infusion
Centers providing biologic infusions for rheumatoid arthritis, lupus, and autoimmune conditions.
Find Outpatient Infusion Centers acquisition targets
Search Acquisera’s index for companies classified under Outpatient Infusion Centers (4.10.18) and build a targeted deal pipeline.
Search companies